Growing prevalence of target conditions such as neurological disorders, autoimmune and cardiovascular diseases across the world is the primary growth driver of the global brain monitoring devices market.
Brain monitoring devices are used to monitor and diagnose abnormal activities in the brain. Brain monitoring devices assist in monitoring electrical and neural activity in the brain. In addition, they help in monitoring the blood flow in the veins and arteries situated in the brain.
The presence of high incidence rates of diseases leading to brain disorders such as epilepsy, Alzheimer’s disease, brain tumors, and multiple sclerosis will also serve this market as high impact rendering drivers. According to the estimates of the WHO in 2011 the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively.
Improvement in functionality, user-friendliness and cost-effectiveness of new brain monitoring devices enabled with technological advancements and the growing demand for brain monitoring devices in the pre-surgery and post-surgery stages will fuel the future growth of this market. Rising installations and demand for brain monitoring devices in critical care settings such as the ICU (intensive care unit) will also ensure the healthy growth of this market in the future.
The electroencephalograph market is one of the largest product segments in this market. High prevalence of epilepsy and sleep disorders coupled with the presence of high unmet medical needs in these segments attribute for its market share. In terms of geography, this market is dominated by the North American region owing to the high market penetration of digital and mobile medical devices in this region supported by the presence of high healthcare expenditure and sophisticated healthcare infrastructure. Growing base of the geriatric population in the U.S. coupled with the presence of high patient awareness levels will also serve the North American brain monitoring devices market as drivers.
This research study encompasses a competitive landscape of the brain monitoring devices market. Revenue analysis, product benchmarking, and strategic developments of key market players such as Covidien PLC, Advanced Brain Monitoring Inc., Elekta AB, Cadwell Laboratories Inc., Nihon Kohden Corporation, Integra LifeSciences Holdings Corporation, and others are also provided in this report.
Grand View’s market research study takes a closer look at the brain monitoring devices industry, providing a holistic perspective on market dynamics, trends, supply, and demand. Our report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro-level. The study aims at providing granular information, regarding estimates and forecasts for key product segments including electroencephalograph, cerebral oximeters, magnetoencephalograph systems, transcranial doppler and intracranial pressure monitors with yearly forecast up to 2020. The report also provides the same level of information for key regional markets of North America, Europe, Asia Pacific, and RoW (rest of the world).
The research report analyzes various factors which have been driving and inhibiting the global brain monitoring devices market in the past. In addition, the research report analyzes the impact of each driver and restraint on the market growth based on which the market is forecasted. The report also showcases the opportunities available in the market which may act as future drivers for the market.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.